Afimkibart trials for Ulcerative colitis

All Afimkibart trials · All Ulcerative colitis trials

Phase breakdown

Recruiting trials studying Afimkibart for Ulcerative colitis

• A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
  NCT06588855 · Phase: Phase 3 · Ages: 16 Years to 80 Years · Sex: All (male and female) · 200 locations
• A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
  NCT07158242 · Phase: Phase 3 · Ages: 2 Years to 17 Years · Sex: All (male and female) · 22 locations
• An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
  NCT07665723 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · 17 locations

Common questions

How many trials study Afimkibart for Ulcerative colitis?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.